Research Blog
-
Vanderbilt, Boehringer Ingelheim announce partnership to develop therapies for psychiatric disorders
Boehringer Ingelheim and Vanderbilt Center for Neuroscience Drug Discovery today announced two new global agreements to investigate, develop and commercialize novel small molecules targeting two distinct G-protein coupled receptors known to engage in the modulation of certain brain circuitries, which are altered in neuropsychiatric conditions such as schizophrenia. Read MoreJan 3, 2019
-
New PET/CT scanner set to expand research opportunities
A research-dedicated PET/CT scanner installed recently in the Vanderbilt University Institute of Imaging Science (VUIIS) will expand opportunities for Vanderbilt researchers to conduct studies of a wide range of disorders, from cancer to Alzheimer’s disease. Read MoreJun 7, 2018
-
Grant bolsters kidney cancer immunotherapy research
W. Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer. Read MoreMay 10, 2018
-
Agreement renewal bolsters liver tumor research
Sirtex Medical Ltd. has renewed a grant award to Dan Brown, MD, professor of Radiology and Radiological Sciences and chief of Interventional Oncology, and his Vanderbilt Health colleagues, for a research program designed to treat patients with liver tumors that cannot be addressed with surgery. Read MoreApr 12, 2018
-
VICC breast cancer leaders named Komen Scholars
Ingrid Mayer, MD, MSCI, Ingram Professor of Cancer Research and leader of the Breast Cancer Research Program at Vanderbilt-Ingram Cancer Center (VICC), has been named a Komen Scholar for her leadership in breast cancer research. Read MoreApr 12, 2018
-
Research lab honored by World Vaccine Congress
The laboratory of James Crowe Jr., MD, director of the Vanderbilt Vaccine Center, received the 2018 Vaccine Industry Excellence Award for Best Academic Research Team at the 18th World Vaccine Congress in Washington, DC, this week. Read MoreApr 12, 2018
-
Lovly earns scholarship grant for lung cancer research
Christine Lovly, MD, PhD, assistant professor of Medicine at Vanderbilt, has received a $200,000 grant to support promising new research on lung cancer. Read MoreMar 8, 2018
-
Research conducted by medical students recognized at events
Vanderbilt-Ingram Cancer Center, Meharry Medical College and Tennessee State University Cancer Partnership recently hosted the 2018 annual retreat and poster contest, “Health Disparities in Cancer Immunology & Immune Therapy.” Read MoreMar 8, 2018
-
AAAS, chemistry society honor Lindsley’s research contributions
Craig Lindsley, PhD, co-director of the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD), has been named a fellow of the Royal Society of Chemistry and elected chair-elect of the Section of Pharmaceutical Sciences of the American Association for the Advancement of Science (AAAS). Read MoreFeb 1, 2018
-
Multicenter trial to test new liver transport system
The growing list of patients needing liver transplants continues to outpace the number of available donor organs, but a new preservation and transport device for donor livers could possibly make a big difference. Read MoreJan 4, 2018
-
Crowe elected a fellow of the National Academy of Inventors
James Crowe Jr., MD, director of the Vanderbilt Vaccine Center at Vanderbilt University Medical Center (VUMC), has been named a fellow of the National Academy of Inventors (NAI). Read MoreDec 14, 2017
-
Matrix biology society honors Hudson’s contributions
Vanderbilt University Medical Center (VUMC) biochemist Billy Hudson, PhD, has been awarded the 2018 Distinguished Investigator Prize by the International Society for Matrix Biology for his contributions to the field of matrix biology. Read MoreDec 14, 2017
-
Vanderbilt researchers’ papers among those most cited
Eight current faculty members at Vanderbilt have made this year’s list of scientists whose papers have been cited most frequently by other researchers. Read MoreDec 7, 2017
-
Niswender named Clinical Research Center director
Kevin Niswender, MD, PhD, whose work has helped advance understanding of the neural underpinnings of obesity and metabolic syndrome, has been named director of the Clinical Research Center (CRC) at Vanderbilt University Medical Center (VUMC). Read MoreNov 30, 2017
-
Conference brings researchers, community advocates together
All too often, community and research are disconnected. Clinical studies move forward with little to no input from the populations they impact, and local voices are left out of the conversation. Read MoreNov 30, 2017
-
Forum highlights strong clinical, translational research efforts
Clinical and translational research at Vanderbilt University Medical Center (VUMC) is thriving. Read MoreOct 19, 2017
-
Researcher targets peanut allergies with Cohen Fund support
Scott Smith, M.D., Ph.D., assistant professor of Medicine, has received a 2017 research award from the Stanley Cohen Innovation Fund to test a new therapeutic strategy for peanut allergies. Smith's research could fundamentally change allergy treatment. Read MoreOct 12, 2017
-
VIGH receives federal grants to fight kidney disease
Researchers in the Vanderbilt Institute for Global Health (VIGH) have received two new grants from the National Institutes of Health (NIH) aimed at reducing the risk of kidney disease in HIV-infected adults and improving the treatment of epilepsy in children in Nigeria. Read MoreOct 12, 2017
-
Major international study testing therapy to prevent spread of HIV
Nine more volunteers are needed to complete a study at Vanderbilt University Medical Center (VUMC) that could lead to a way to prevent the spread of HIV (human immunodeficiency virus). Read MoreOct 5, 2017
-
Mayor to speak at Center for Addiction Research science day
Nashville Mayor Megan Barry will speak during a “science day,” Tuesday, Oct. 17, at the Belcourt Theatre hosted by the Vanderbilt Center for Addiction Research (VCAR). Read MoreOct 5, 2017